1.
Frisch A, Krayem B, Zuckerman T, Henig I, Yehudai-Ofir D, Glaubach N. Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2026Mar.5];. Available from: https://haematologica.org/article/view/13380